Home

Our Technology

Our platform technology unlocks the robust immuno-resolving properties of endogenous bioactive lipids to create novel, non-immunosuppressive therapies for treatment of Inflammatory Bowel Disease (IBD).

Proven Lipid Biology

Leveraging the robust immuno-resolving properties of endogenous bioactive lipids

HEALER™ Platform

Chemically transforming endogenous bioactive lipids into small molecules with superior pharmaceutical properties

Intellectual Property

Long-term composition of matter patent protection on new molecular entities via the HEALER platform

"We are committed to creating innovative products that improve the lives of patients suffering from IBD."

Our Approach

Thetis agents offer a unique disease-modifying approach to IBD treatment based on dampening inflammation and promoting tissue repair and healing without suppressing normal immune function.